 oxygenation in affected areas. Porter
et al91 revealed its effectiveness compared with placebo in a
double-blind, placebo-controlled trial conducted at seven centers with use in outpatients. Pentoxifylline increased pain-free
and maximal walking distance compared with placebo. Despite
its signiﬁcant ﬁndings in the Porter trial, clinical use of the drug
has been limited due to the difﬁculty in identifying the IC
patient who will predictably beneﬁt.